Quality Standard:【产品介绍】T lymphocytes undergo proliferation arrest
when exposed to tryptophan shortage, which can be
provoked by indoleamine 2,3-dioxygenase (IDO), an
enzyme that is expressed in placenta and
catalyzes tryptophan degradation. Most human
tumors constitutively express IDO. Results suggest that
the efficacy of therapeutic vaccination of cancer
patients might be improved by concomitant administration
of an IDO inhibitor (1). Certain macrophages, induced
to express IDO in response to interferon-gamma and
other signals from activating T cells, inhibit
T-cell proliferation in vitro by rapidly
consuming tryptophan. Because IDO is also expressed by
human syncytiotrophoblast cells and systemic
tryptophan concentration falls during normal pregnancy,
it is believed that IDO expression at the maternal-
fetal interface is necessary to prevent
immunologic rejection of the fetal allografts (2).
Recommended Applications
WB
Applications and Recommended Dilution Factors
WB: 1:1,000 - 10,000
Species Reactivity *
Human
*Species cross-reactivity is based on WB analysis.
Products Data
Western blot analysis on HeLa treated with IFN-gamma
cell lysate using anti-IDO RabMAb (cat. #5133-1).
Specificity
A synthetic peptide corresponding to residues in human
IDO was used as an immunogen.